(IN BRIEF) Eckert & Ziegler has secured MDR certification for its Ru-106 eye applicators, ensuring continued availability of a critical treatment for eye cancer patients in the EU. The devices, used in brachytherapy procedures for conditions such as uveal melanoma … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged brachytherapy, Eckert & Ziegler, Eckert & Ziegler BEBIG, Eckert & Ziegler Reinforces Medical Technology Leadership with Approval of Niche Eye Cancer Treatment Devices, European Union, eye applicators, healthcare technology, Katrin Antonenko, MDR Certification, MDR Certification Strengthens Availability of Critical Brachytherapy Devices for Eye Tumor Treatment Across EU, Medical Device Regulation, medical devices, oncology, patient care, radiation therapy, retinoblastoma, Ru 106, uveal melanoma
(IN BRIEF) Novo Nordisk has received approval from the European Medicines Agency to update the delivery conditions for Wegovy® injection, allowing it to be transported at temperatures of up to 30°C for up to 48 hours. This makes it the … Read the full press release
Posted in Business, Denmark, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged cardiovascular risk reduction, cold chain distribution, digital health, direct to patient delivery, eHealth, EMA approval, Europe pharmaceutical regulation, European Medicines Agency, GLP-1 treatment, healthcare supply chain, home delivery medicines, MASH treatment, Mike Doustdar, Novo Nordisk, Novo Nordisk Advances European Access to Wegovy with New 48-Hour Controlled Temperature Delivery Approval, Obesity Treatment, pharmaceutical logistics, Semaglutide, Wegovy, weight management
(IN BRIEF) Unilever has agreed to acquire Grüns, a fast-growing U.S.-based supplements company known for its innovative gummy-based greens products, as part of its strategy to expand into premium and high-growth segments within the Beauty & Wellbeing category. Founded in … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged Amazon, beauty and wellbeing, Chad Janis, consumer health, Costco, digital native brands, greens supplements, Grüns, gummy supplements, health and wellness industry, Jostein Solheim, mergers and acquisitions, nutrition products, Sam's Club, Sprouts Farmers Market, supplements industry, target, Unilever, Unilever Moves to Acquire Grüns to Scale Innovative Greens Supplement Brand Across Global Wellbeing Business, US market expansion, vitamin mineral supplements VMS, Walmart, wellness market
(IN BRIEF) EQT Life Sciences has exited its investment in Tubulis following Gilead Sciences’ agreement to acquire the German biotechnology company in a deal valued at up to $5 billion including milestones. EQT supported Tubulis’ development into a clinical-stage oncology … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Sweden, Technology
Tagged ADC platform, antibody-drug conjugates, biotechnology acquisition, Cancer Therapies, Christoph Broja, clinical-stage biotech, Dominik Schumacher, EQT Life Sciences, EQT Life Sciences Realizes Investment Success with Sale of Tubulis to Gilead Sciences, EQT Life Sciences Supports Growth of Tubulis Leading to Major Acquisition by Gilead Sciences, Gilead Sciences, Munich biotech, oncology investment, pharmaceutical industry, Tubulis
(IN BRIEF) Novonesis has agreed to acquire a fermentation production facility in Rayong, Thailand from Meihua for approximately USD 50 million, expanding its footprint in Southeast Asia. The facility will enhance the company’s global production capabilities and support its long-term … Read the full press release
Posted in Business, Denmark, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Anders Lund, biosolutions, emerging markets, fermentation facility, global manufacturing, GROW strategy, HMO, Human Milk Oligosaccharides, Meihua, Novonesis, Novonesis Advances Growth Strategy with Acquisition of Key Biosolutions Facility in Thailand, Novonesis Invests in Thailand Production Capacity to Support Rising Demand for BioSolutions, Novonesis Strengthens Global Production Network Through Investment in Thailand Manufacturing Site, production capacity, Rayong Thailand, Southeast Asia expansion
(IN BRIEF) Sanofi has announced positive phase 2 clinical results for lunsekimig, a novel bispecific therapy targeting key inflammatory pathways in respiratory diseases. The treatment successfully met primary and key secondary endpoints in studies involving moderate-to-severe asthma and chronic rhinosinusitis … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Security & Safety, Technology
Tagged asthma treatment, atopic dermatitis, biologic therapy, chronic rhinosinusitis with nasal polyps, clinical trials, CRSwNP, drug development, Houman Ashrafian, IL13, lunsekimig, Nanobody VHH, Phase 2 study, respiratory diseases, Sanofi, Sanofi Advances Respiratory Pipeline with Promising Clinical Data for Dual Targeting Lunsekimig Therapy, Sanofi Reports Positive Phase 2 Results for Lunsekimig in Asthma and Respiratory Diseases Development, TSLP
(IN BRIEF) TÜV Rheinland Vietnam has launched new biodegradability and VOC emission testing services to help Vietnamese manufacturers meet international environmental standards and strengthen their competitiveness in global markets. These services address growing regulatory and consumer demands for transparency in … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Security & Safety, Technology
Tagged biodegradability testing, Bioplastics, circular economy, CPSIA testing, DIN CERTCO, eco-friendly materials, environmental standards, European standards EN 717 1 EN 16516 ISO 16000, global compliance, Ho Chi Minh City laboratory, ISO/IEC 17025, packaging plastics textiles automotive industries, sustainability certification, sustainable development, TÜV Rheinland Vietnam, TÜV Rheinland Vietnam Strengthens Support for Sustainable Manufacturing with New Testing Services and DIN CERTCO Accreditation, Vietnam manufacturing, VOC emissions testing
(IN BRIEF) Beiersdorf has introduced a €100 million second-generation Skin Care Innovation Fund to expand its venture capital activities and support innovation in skin care. The fund focuses on startups in life sciences, sustainability, AI, and digital health, investing globally … Read the full press release
Posted in Apparel, Fashion & Beauty, Artificial Intelligence (AI), Business, Environment, Financial, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged artificial intelligence, Ascan Voswinckel, Beiersdorf, Beiersdorf Strengthens Global Innovation Ecosystem with Second Generation Skin Care Investment Fund, biotechnology, corporate venture capital, DePoly, digital health, Gitta Neufang, innovation ecosystem, life sciences, longevity science, Melt and Marble, microbiome research, R&D, S Biomedic, skin care innovation, Skin Care Innovation Fund, sustainability, turbine, venture capital, Vincere Biosciences
(IN BRIEF) Researchers from The Institute of Cancer Research and The University of Manchester have created the most comprehensive map of cancer-related genetic mutations to date, analysing data from nearly 11,000 patients in the 100,000 Genomes Project. The study identified … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged 100000 Genomes Project, bowel cancer, breast cancer, cancer genomics, David Wedge, DNA mutations, Genomics England, homologous recombination deficiency, HRD, Institute of Cancer Research London, Landmark Study Advances Precision Oncology with Comprehensive Mapping of Cancer-Causing Genetic Mutations, Major Cancer Genomics Study Uncovers New Mutation Signatures Expanding Potential for Precision Treatments, microbiome, mutational signatures, oncology research, ovarian cancer, PARP inhibitors, precision medicine, Richard Houlston, University of Manchester
(IN BRIEF) New research published in the European Heart Journal reveals that even short periods of vigorous physical activity can significantly reduce the risk of major diseases, including heart disease, diabetes, inflammatory conditions, and dementia. The study, based on data … Read the full press release
Posted in Business, Education, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Society, Technology
Tagged accelerometer study, Arthritis, cardiovascular disease, chronic disease prevention, dementia, Diabetes and Cardiovascular Disease, European Heart Journal, European Society of Cardiology, exercise intensity, health research, inflammation, International Research Suggests Small Amounts of Vigorous Activity Can Improve Long-Term Health Outcomes, lifestyle health, Minxue Shen, mortality risk, physical activity, public health, Study Finds Exercise Intensity Plays Key Role in Lowering Risk of Dementia, type 2 diabetes, UK Biobank, vigorous exercise
(IN BRIEF) GSK has announced that China’s National Medical Products Administration has accepted for review a New Drug Application for bepirovirsen, an investigational antisense oligonucleotide designed to treat adults with chronic hepatitis B. The submission is supported by Phase III … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, Science, United Kingdom
Tagged antisense oligonucleotide, ASO therapy, B-Well 1 trial, B-Well 2 trial, Bepirovirsen, breakthrough therapy designation, CHB, China healthcare, chronic hepatitis B, clinical trials, drug development, functional cure, GSK Moves Closer to Transforming Chronic Hepatitis B Care with Bepirovirsen NDA Review in China, GSK plc, GSK Strengthens Infectious Disease Portfolio with Regulatory Submission for Novel Hepatitis B Therapy in China, HBsAg, hepatitis B surface antigen, infectious disease, liver cancer, National Medical Products Administration, NMPA, viral infection
(IN BRIEF) GSK has secured approval in China for Exdensur (depemokimab), a first-of-its-kind ultra-long-acting biologic for treating severe eosinophilic asthma in patients aged 12 and above. Approved by China’s National Medical Products Administration, the therapy offers a novel treatment approach … Read the full press release
Posted in Business, Healthcare, Marketing, Pharma & Biotech, Science, United Kingdom
Tagged asthma exacerbations, asthma treatment, biologic therapy, biologics, China healthcare, chronic rhinosinusitis with nasal polyps, clinical trials, CRSwNP, Depemokimab, eosinophilic asthma, Exdensur, GSK Advances Asthma Treatment Innovation with NMPA Approval of Exdensur for Eosinophilic Severe Asthma in China, GSK Introduces Ultra-Long-Acting Biologic Exdensur to Address Severe Asthma Burden in China Healthcare System, GSK plc, Kaivan Khavandi, National Medical Products Administration, NMPA, respiratory disease, Severe Asthma, SWIFT-1 trial, SWIFT-2 trial, type 2 inflammation
(IN BRIEF) Roche has launched the cobas MPX-E assay, a multiplex molecular diagnostic test capable of detecting HIV, Hepatitis B, Hepatitis C, and Hepatitis E simultaneously in a single workflow. Available in CE mark–accepting markets, the assay is designed to … Read the full press release
Posted in Healthcare, Industrial, Pharma & Biotech, Science, Switzerland, Technology
Tagged blood donor screening, CE Mark, cobas 5800, cobas 8800, cobas MPX-E, cobas x800 systems, cobas® 6800, HBV, HCV, Healthcare Innovation, Hepatitis B, hepatitis C, Hepatitis E, HEV, HIV, In Vitro Diagnostics, laboratory automation, Matt Sause, Molecular Diagnostics, NAT blood screening, PCR testing, Roche, Roche Diagnostics, Roche Introduces cobas MPX-E Test to Enhance Laboratory Efficiency and Strengthen Global Blood Safety Standards, Roche Launches High-Throughput Multiplex Diagnostic Assay to Streamline Detection of HIV and Hepatitis Viruses, viral detection
(IN BRIEF) Almirall has signed a collaboration and licensing agreement with Shanghai Huaota Biopharmaceutical, a subsidiary of Zhejiang Huahai Pharmaceutical, to develop a monoclonal antibody candidate for multiple indications including medical dermatology, with Huaota leading early research and initial clinical … Read the full press release
Posted in Business, Healthcare, Management, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Almirall and Huaota Enter Global Licensing Agreement to Develop Monoclonal Antibody for Multiple Indications, Barcelona, biologics, biopharmaceutical, CHINA, clinical development, Cutia, INNOVATION, Karl Ziegelbauer, licensing agreement, medical dermatology, monoclonal antibody, pharmaceutical partnerships, R and D, Shanghai Huaota Biopharmaceutical, Simcere, Sinomune, Zhejiang Huahai Pharmaceutical
(IN BRIEF) Evotec SE’s subsidiary Just – Evotec Biologics has been selected by the Biomedical Advanced Research and Development Authority BioMaP Consortium to support a multi-year initiative aimed at improving manufacturing processes for antibody-based treatments targeting Ebola and Sudan virus. … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged antibody development, ASPR, BARDA, biologics manufacturing, BioMaP Consortium, Ebola virus, Evotec SE, Evotec Strengthens Biomanufacturing Capabilities Through U.S.-Backed Program Targeting Emerging Viral Outbreaks, filovirus infections, global health security, Just – Evotec Biologics, monoclonal antibody therapy, outbreak preparedness, scalable production, Sudan virus, U.S Department of Health and Human Services
(IN BRIEF) GSK plc has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate risvutatug rezetecan (Ris-Rez) for the treatment of small-cell lung cancer, supported by early clinical data showing durable responses in patients with extensive-stage disease. SCLC, … Read the full press release
Posted in Business, Healthcare, Marketing, Pharma & Biotech, Science, Security & Safety, United Kingdom
Tagged antibody-drug conjugate, ARTEMIS-001, B7-H3, breakthrough therapy designation, clinical trials, colorectal cancer, EMA, ES SCLC, extensive stage SCLC, FDA, GSK, GSK advances investigational cancer therapy risvutatug rezetecan with sixth global designation supporting development in solid tumours, Hansoh Pharma, Japan Ministry of Health Labour and Welfare, lung cancer, oncology, orphan drug designation, Phase III Trial, PRIME designation, prostate cancer, Ris Rez, risvutatug rezetecan, SCLC, Small cell lung cancer
(IN BRIEF) CVC Capital Partners has agreed to sell a 37% minority stake in Syntegon to Apollo-managed funds while retaining majority ownership, marking the start of a new growth phase for the company. Since CVC’s investment, Syntegon has achieved strong … Read the full press release
Posted in Business, Food & Beverage, Industrial, Infrastructure & Utilities, Insurance, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Apollo, biotechnology, Can Toygar, CVC and Apollo partnership strengthens Syntegon’s expansion plans and leadership in pharma biotech and food technology markets, CVC Capital Partners, food industry, Global Growth, industrial technology, INNOVATION, investment, Jeremy Honeth, Klenzaids, manufacturing systems, Marc Strobel, Minority Stake, North America expansion, pharma industry, private equity, Stuttgart, Syntegon, Telstar, Torsten Türling
(IN BRIEF) Novartis has agreed to acquire SNV4818 from Synnovation Therapeutics, a next-generation PI3Kα inhibitor designed to selectively target mutations in HR+/HER2- breast cancer. The therapy, currently in Phase 1/2 clinical trials, aims to improve treatment tolerability by focusing on … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged Breast Cancer Treatment, cancer research, clinical trials Phase 1/2, HR positive HER2 negative, Novartis, Novartis Strengthens Breast Cancer Portfolio with Acquisition of Next Generation Selective PI3Kα Therapy, oncology pipeline, pharmaceutical acquisition, PI3Kα inhibitor, PIK3CA mutation, Pikavation Therapeutics, precision medicine, SNV4818, solid tumors, Synnovation Therapeutics, targeted therapy
(IN BRIEF) Researchers at the Paul Scherrer Institute have identified the molecular mechanism behind a light-switchable drug that can modulate its effectiveness in treating high blood pressure. By observing how the compound changes shape and interacts with its receptor, the … Read the full press release
Posted in Business, Energy, Gas & Oil, Healthcare, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged beta blockers, biomedical innovation, Consejo Superior de Investigaciones Científicas, drug design, High blood pressure, Jörg Standfuss, leadXPro, light switchable drugs, molecular research, Paul Scherrer Institute, photoazolol 1, photopharmacology, precision medicine, PSI, PSI Researchers Reveal Molecular Mechanism Behind Light Switchable Blood Pressure Drug, PSI Unlocks New Insights into Precision Medicine Through Light Activated Drug Innovation, Quentin Bertrand, SwissFEL, targeted therapy, β adrenergic receptors
(IN BRIEF) UKRI has announced a major infrastructure investment package, including £51.2 million for a new National Cryogenic Facility that will enable advanced research at ultra-low temperatures. The facility will support innovation in areas such as quantum computing, healthcare, and … Read the full press release
Posted in Business, Energy, Gas & Oil, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adam Staines, bioimaging, Blue Horizon, clean energy, cryogenic research, Daresbury Laboratory, food security, Ian Chapman, IMAS UK, infrastructure fund, National Cryogenic Facility, PhenomUK, plant science, quantum computing, research infrastructure, superconductors, tidal power, UK innovation, UKRI, UKRI Expands Research Infrastructure Portfolio with Strategic Investments Across Science Technology and Agriculture, UKRI Unveils Multi Million Pound Funding Package to Accelerate Scientific Innovation and Economic Growth Across the UK
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?